Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Relief Therapeutics posted for the fist time on Linked In about 2 hours ago.
https://www.linkedin.com/posts/relief-therapeutics-holding-sa_providing-patients-therapeutic-relief-from-activity-6727137806059208704-0iBu
Thanks to everyone for sharing your knowledge. Especially Uncle Gee Gee and aGuy,Lots learned and I hope to continue learning from folks like you.
I hope the best for all in the few days.
I thought you were not gonna catch that. LOL I guess I was caught.
Good eye, it fits Bausch Health line of products.
Bausch Health develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health, and neurology.
It is a possibility.
Sounds like I want to buy my Grammy or (Edison).
Thanks for the info. I can't imagine going through it once, let alone 3 times, May he RIP.
Firefighter in Houston died of COVID after 3rd time contracting it. They gave him RLF-100 in ICU but sadly it was too late for him, COVID had taken over by the time he was given the peptide. They tested him right before his death and tested negative.
https://abc13.com/brother-of-houston-firefighter-who-died-covid-19-honors-his-life-tommy-searcy-fire-tony-department-coronavirus-death/6426370/
Hi Bill. That was from a video from Dr. Yo's youtube channel. go to the end of the video.
Those numbers are based on just 1 product with 2 delivery systems.
Relief and Neuro have other products in their pipeline. Who knows what may come out of the patents they already have.
Crazy how they happened to "stumble upon" RLF-100 in a "dusty file cabinet"
As always, your DD is impecable. Thank you.
I think this can hit $4 to $5 quick. Then it will continue to go higher. Or due to such a bad market people panicking will start bidding to who knows what number. How much higher? Who knows! Especially after the Inhaled Aviptadil is launched. People have thrown so many numbers around from $3 to $12 to 50 to $70 to potential over $100. Who knows.
Found this interesting.
Major Key Players of the Cardiac Sarcoidosis Market
Teva Pharmaceuticals USA, (A Subsidiary Of Teva Pharmaceutical Industries Ltd.), Hikma Pharmaceuticals PLC, Genentech, (A subsidiary of F. Hoffmann-La Roche Ltd), sanofi-aventis U.S. LLC, Mylan N.V., Zydus Pharmaceuticals (USA) (A Subsidiary Of Zydus cadila ), Amneal Pharmaceuticals Araim Pharmaceuticals Mallinckrodt, AbbVie, Pfizer, RELIEF THERAPEUTICS Holding SA, Sandoz AG (A Subsidiary of Novartis AG), Fresenius Kabi USA (A subsidiary of Fresenius SE & Co. KGaA), Merck Sharp & Dohme Corp. (A Subsidiary of Merck & Co.,), Salix Pharmaceuticals (A Subsidiary of Bausch Health Companies), Janssen Pharmaceuticals,( a subsidiary of Johnson & Johnson Services) among others.
https://www.pharmiweb.com/press-release/2020-10-27/cardiac-sarcoidosis-market-opportunity-analysis-and-industry-forecast-2020-2027-mylan-nv-zydu
I totally Agree!
NY POST mentions RLF-100: https://nypost.com/article/potential-covid-19-treatments/
It's all about timing. We have an election in less than 10 days. Remember what happened about a week from the 2016 election. I hate to think about it. But RLF can be used as another election tool to get some votes.
Thanks tcm55
Regarding GEM's price point. They got 707,475,186 shares. They invested 58 million. That comes up to around .081 cents per share.
At what point will they hit the eject button? $8.10 pps= 5.7B
or will they wait to 1,000% or $81 pps = 57B?
5 minutes in volume 1.155 million shares ...
There is not much left now for RLFTF to stay under the radar. This is the beginning of the rocketship countdown.
Relax! The agreement between the NeuroRx and Relief has them sharing the profits of RLF-100, 50/50 US, Canada and Israel. 80/20 Europe, 85/15 worldwide.
Anything NeuroRx does with RLF-100,Relief gets minimum 50%.
One of the questions I kept asking myself was "What does the agreement between NeuroRX and Relief look like?" I found this article that gives a little detail on how the profits will be split between the companies. I don't know if it was posted previously.
https://www.genengnews.com/covid-19-candidates/covid-19-definitely-maybe/relief-therapeutics/
"On September 21, Relief and NeuroRx completed their partnership agreement for the commercialization of RLF-100™(Aviptadil) worldwide. Under the agreement—whose value was not disclosed—the two companies agreed to share all profits from sales of RLF-100 for all indications related to COVID-19 and potentially other respiratory indications on a global basis. NeuroRx will lead commercialization in the United States, Canada, and Israel, while Relief will lead commercialization in Europe and the rest of the world.
Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada, and Israel; 85/15 in favor of Relief in Europe; and 80/20 in favor of Relief elsewhere in the world. NeuroRx agreed to pursue trademarks for RLF-100 in the U.S., Canada and Israel, with Relief doing so in all other territories."
If this is the case, the agreement is pretty much a great deal for Relief.
Merck looks like the BP company that NeuroRX will be merging with.
From Dr. Yo’s discussion with Dr J. September 30, 2020. (last question and answer)
Dr. Yo: What is the take home message that they can look forward to in the future in something we should all be excited about?
Dr. J: “Well I think we’re gonna learn an awful lot 28 days from now. And uh… I can’t tell you what we’re going to learn, I hope that what we learn is consistent with what we’ve already seen in the 21 Christian study.
We are encouraged by the dumb’s ruling in july…uh… in identifying that they didn’t see a safety problem, they didn’t see a problem with futility, but we are going to learn a lot in 28 days.”
This is why I am calm about waiting until October 28, 2020.
One down... Neuro/Relief seem to be in the driver seat in the VIP/COVID market
It has nothing to do with the Swiss being dumb or not. The reality is that this was a PR race about who was going to be the first to be announced as an FDA approved therapy. Gilead won that. It is normal for people to fall into the marketing of it all. Gilead can pump their chest and say "We were the first" not necessarily the best, but the first FDA approved therapy. That enough will make some money. They got all the press now we are under the radar ready to strike within a week.
Quote from FDA Authorization:
"...this authorization will be used only to treat suspected or
laboratory-confirmed COVID-19 in hospitalized7 pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg administered via intravenous (IV) infusion by a healthcare provider;
and
• The use of Veklury covered by this authorization should be in accordance with the dosing regimens as detailed in the authorized Facts Sheets.
Official announcement FDA Approval of Remdesivir https://www.fda.gov/media/137564/download
Yes the meeting is still going on. Right now Private Non Profits are presenting their recommendations
The FDA meeting presenters keep stating the importance of not rushing vaccines.
I think everything will be riding on October 28th. That was the date given, that is what I am going by. In the meantime, buying some more.
I hate to get into this but I feel it is the big elephant in the room. The timing of all this is interesting to me. We have October 28 as a date mentioned by Dr. J. That is 5 days from the election. We have Rep. Andy Harris,(friend of Dr. J since their days at John Hopkins) as member of the data and monitoring group for NeuroRX, giving him instant access to the data and WH. RLF-100 is in the FDA Fast Track program. With all those pieces in place, once the data if is revealed that it shows positive results, based on the election polls having POTUS trailing, I can see POTUS pumping this till the election and after. Either way it would be incredible for the SP.
Uncle, the yahoo board has gone bananas. Is like a bunch of hungry refugees waiting for the rescue helicopter to throw them some food. I follow, don't comment much. I just scratch my head with some of the comments.
Government insiders and corporate insiders want their big cut to get this thing rolling. Crony Capitalism. Everyone wants $.
Thank you Unc!